Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
30,412,423
-
Shares change
-
-1,797,037
-
Total reported value, excl. options
-
$892,904,817
-
Value change
-
-$134,999,214
-
Put/Call ratio
-
58%
-
Number of buys
-
62
-
Number of sells
-
64
-
Price
-
$29.37
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q1 2016
As of 31 Mar 2016 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,412,423 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, ORBIMED ADVISORS LLC, Grantham, Mayo, Van Otterloo & Co. LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Point72 Asset Management, L.P., STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC.
This table shows 114 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.